(RTTNews) - Sandoz Group AG (SDZNY), a Swiss generic and biosimilar medicines maker, Tuesday announced that the global generics and biosimilars market, which is worth more than $200 billion in ...
Strong first year as standalone company; global leader Sandoz uniquely positioned in attractive and growing USD 200 billion market for generics and biosimilars Leading in home market Europe, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback